The non-tariff barriers would include the age restriction with the SRMs, and it's basically that they're not fully in compliance with the international standard of how you treat countries that are a controlled risk for BSE. That's the primary one. The other one would be the approval of the further processing facilities. Also, of course, there's the safeguard, which is a kind of tariff, but it's like a non-tariff, as opposed to what tariff you get. It's the unpredictability of knowing what your tariff will be if you reach a certain trigger point.
On May 3rd, 2012. See this statement in context.